Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

How Is Revvity's Stock Performance Compared to Other Diagnostics & Research Stocks?

Waltham, Massachusetts-based Revvity, Inc. (RVTY) is a global provider of health sciences technologies and services. With a market cap of $15.4 billion, the company offers instruments, reagents, software, and solutions for genetic testing, disease detection, and drug discovery, serving pharmaceutical, biotech, and healthcare organizations.

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Revvity fits this criterion perfectly, exceeding the mark. Revvity stands out in the market for its comprehensive integration of advanced informatics and detection technologies that streamline genomic workflows and enhance the early detection of genetic disorders.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.